Skip to content

The “norm and practice” of Pharmaceutical companies is to vehemently deny the most serious adverse side effects of their products. This industry’s success in concealing the truth about the serious harm caused by their drugs and vaccines has been aided and abetted by government officials in the FDA and the CDC. In the case of…

Read More

A recent interview on Mad in America (MIA,  on May 15th) with professor David Cohen, Ph.D  focused on his work on psychiatric coercion. His illuminating insights  provide an understanding of how psychiatry gets away with forced treatment with drugs that have clinically demonstrable  adverse effects. Psychiatry’s authority is relegated by the government – unlike other…

Read More

On June 27, 2016, The New York Times reported that New York University medical school “quietly shut down eight studies at its prominent psychiatric research center” and dismissed Dr. Alexander Neumeister, the studies’ lead investigator was the director of the Molecular Imaging Program for Mood and Anxiety Disorders, and a Professor in the Departments of…

Read More

"The problem of prescription overdose in the military has its parallel in civilian life. The tragic overdose victims in both spheres represent canaries in the coal mine–only the most obvious victims of what has become our national orgy of over using psychotropic drugs."  Allen Frances MD

Read More

According to a report by the Associated Press, the FDA has approved expanded use of Merck’s toxic antipsychotic drug, Saphris, for treating acute manic-depressive behavior in adults. Antipsychotics (neuroleptics) are a controversial class of drugs: Risperdal (approved in 1993), Zyprexa (1994), Seroquel (1997), Abilify (2002), and Saphris (2009). These drugs’ safety hazzards were documented over…

Read More
Scroll To Top